Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study

doi:10.4251/wjgo.v16.i1.118

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2074)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

976

Figures (1-6)

175

Tables (1-4)

198

Sum=1454

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

133

Download

424

Sum=557

Jan 15, 2024 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Jan 15, 2024; 16(1): 118-132
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118

Full Size Figure Download Figure

Figure 6 Diagnostic value of TGF-β1 expression in gastric cancer patients. Receiver operating characteristic (ROC) curves were generated based on TGF-β1 protein expression levels in patient samples. A: ROC curve for TGF-β1 expression in normal and tumor tissues; B-E: Subgroup analysis for stages I, II, III, and IV, respectively.

Citation: Lv SL, Guo P, Zou JR, Chen RS, Luo LY, Huang DQ. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study. World J Gastrointest Oncol 2024; 16(1): 118-132
URL: https://www.wjgnet.com/1948-5204/full/v16/i1/118.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.118